or
Results for US_CLASSIFICATION: 514/544
Showing 1 - 10 of 18107
Pharmaceutical compositions containing alkyl gallates are employed for treating glaucoma.
Compositions and methods for killing dust mites are disclosed. The disclosed miticides are aqueous mixtures composed of benzyl benzoate in an amount effective for killing dust mites and a solvent having a high affinity for benzyl benzoate and for water. The amount of solvent is sufficient to maintain a stable dispersion of benzyl benzoate in the aqueous mixture. Benzyl alcohol, which is itself a miticide, is an especially useful solvent. The miticide optionally contains at least one surfactant, ...
Activation of the Ki-ras proto-oncogene is common in colon carcinogenesis. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit carcinogen-induced colon carcinogenesis, decrease the frequency of Ki-ras mutations in the azoxymethane-treated rat model, and induce apoptosis in a variety of cell types. Sulindac, as well as other non-steroidal anti-inflammatory agents, are provided in combination with DFMO the prevention and/or treatment of cancers characterized by the expression of an activated Ki...
A crystal clear, transparent insect repellent in gel form contains N,N-diethyl-m-toluamide (DEET), water, a lower alcohol, preferably ethanol, carboxypolymethylene as a gelling agent, triethanolamine for neutralizing the gelling agent, methyl and propyl paraben, a perfume for masking the odor of the DEET, and a polysorbate, preferably polyoxyethylene (20) sorbitan monolaurate for improving the texture of the gel.
An alcohol based disinfecting composition which contains from 0.1% to 10% of benzyl benzoate is effective in killing dust mites. The compositions can comprise additional disinfectants and are most conveniently applied in aerosol form with a suitable propellant. Allergens contained in the faecal matter excreted by dust mites can be controlled by removing dead mites and associated faecal matter using a vacuuming apparatus under conditions which do not cause the removed material to vent into the am...
A method for increasing bioavailability of an orally administered pharmaceutical compound comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with propyl gallate. Improved formulations of pharmaceutical compounds include propyl gallate to enhance the bioavailability of the active ingredient of the pharmaceutical compound.
A knockdown article of furniture formed of a plurality of panels. A number of the panels are interengaged by slidably interengaging male and female extruded fittings secured on edges and surfaces of the panels. A further panel is slidable in grooves formed in the slidably interengaged panels and is secured to one of the number of slidably interengaged panels, to lock all of the panels into unitary structure.
Compositions for controlling the growth of microorganisms in or on a product, material or medium comprising synergistically effective amounts of halogenated acetophenones, such as 2-bromo-4-hydroxyacetophenone, and at least one organic acid, its salt or ester are disclosed. Methods to control the growth of microorganisms and prevent spoilage caused by microorganisms with the use of the compositions of the present invention are also disclosed.
Compounds of the formula ##SPC1## Wherein R.sub.1 represents a phenyl, phenoxy, phenylthio or cyclohexyl radical which is optionally substituted by halogen, nitro, alkyl and/or alkoxy, or a phenyl or cyclohexyl radical which is bonded via an alkylene, alkyleneoxy or alkylenethio bridge member, R.sub.2 represents cyano, carbamoyl, an alkoxycarbonyl, alkenyloxycarbonyl, alkinyloxycarbonyl, alkylcarbamoyl or dialkylcarbamoyl radical and R.sub.3 represents hydrogen or alkyl, their manufacture and ag...
The hydrochloride salt of 1-morpholinomethyl-5-ethyl-5-phenyl barbituric acid has been provided by the reaction of 5-ethyl-5-phenyl barbituric acid with morpholine, hydrochloric acid and formaldehyde. The use of this compound and 1-morpholinomethyl-5-ethyl-5-phenyl barbituric acid as anticonvulsants, and therapeutic compositions containing the same are also disclosed.
1 2 3 4 5 6 7 8 9 10
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us